Stocktoria
Strata Critical Medical, Inc. SRTA
Nasdaq · XNAS · stock · Services-Health Services · website · IPO 2019-09-17
Strata Critical Medical, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $197.1M | $146.8M | $225.2M | $146.1M | $50.5M |
| Gross profit | $41.1M | $29.6M | — | — | — |
| SG&A expense | $60.9M | $50.9M | — | — | — |
| Operating income | -$22.4M | -$22.5M | -$68.1M | -$53.5M | -$24.1M |
| Income tax | $0 | $0 | -$1.5M | -$772,000 | -$3.6M |
| Net income | $41.3M | -$27.3M | -$56.1M | -$27.3M | -$40.1M |
| EPS (diluted) | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 |
| Operating cash flow | -$48.9M | -$2.5M | -$32.3M | -$37.1M | -$15.6M |
| Free cash flow | -$58.5M | -$33.4M | -$34.5M | -$37.9M | -$15.9M |
| Cash & equivalents | $31.0M | $18.4M | $27.9M | $41.3M | $7.0M |
| Total assets | $325.5M | $256.7M | $294.9M | $325.0M | $343.4M |
| Total liabilities | $46.4M | $34.7M | $60.6M | $50.5M | $52.2M |
| Shareholders' equity | $279.1M | $221.9M | $234.3M | $274.5M | $291.2M |
Source: SEC EDGAR filings · CIK 0001779128 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.